StonvexLoading…
StonvexStonvexStonvexCore line items from MDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-04-25 | Annual 2024 2024-04-26 | Annual 2023 2023-04-28 | Annual 2022 2022-04-29 |
|---|---|---|---|---|
Revenue | $33.54B | $32.36B | $31.23B | $31.69B |
Operating Income | $5.96B | $5.14B | $5.49B | $5.75B |
Net Income | $4.66B | $3.68B | $3.76B | $5.04B |
EPS (Diluted) | $3.61 | $2.76 | $2.82 | $3.73 |
Total Assets | $91.68B | $89.98B | $90.95B | $90.98B |
Total Liabilities | $43.42B | $39.56B | $39.28B | $38.26B |
Cash & Equivalents | $2.22B | $1.28B | $1.54B | $3.71B |
Free Cash Flow OCF − CapEx | $5.18B | $5.20B | $4.58B | $5.98B |
Shares Outstanding | 1.28B | 1.31B | 1.33B | 1.33B |